ORIGINAL RESEARCH article
Front. Psychiatry
Sec. Mood Disorders
Volume 16 - 2025 | doi: 10.3389/fpsyt.2025.1677304
Global, Regional, and National Trends in the Burden of Bipolar Disorder Among Women of Reproductive Age from 1990 to 2021, and Projections to 2041: A Systematic Analysis from the Global Burden of Disease Study 2021
Provisionally accepted- 1Second Affiliated Hospital of Nanchang University, Nanchang, China
- 2Daizhuang Hospital, Jining City, Shandong Province, Jining City, Shandong Province, China
- 3The Fourth People's Hospital of Wuhu, Wuhu, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Bipolar disorder (BD) is a severe psychiatric illness. Women of reproductive age (15–49 years) are at higher risk due to hormonal, reproductive, and social factors. Despite its substantial personal and public health burden, systematic evidence based on recent Global Burden of Disease (GBD) data remains limited. Methods:This study used GBD 2021 data to assess incidence, prevalence, and DALYs of BD among women aged 15–49 globally, regionally, and nationally from 1990–2021. We calculated age-standardized incidence rate (ASIR), prevalence rate (ASPR), and DALYs rate (ASDR), along with the estimated annual percentage change (EAPC) , evaluated health inequality, and projected trends to 2041 using a Bayesian age–period–cohort model. Results:From 1990 to 2021, the burden of BD among women aged 15–49 years increased significantly worldwide. In 2021, the numbers of new cases, prevalent cases, and DALYs were all higher than in 1990. Although the ASIR slightly declined (EAPC=−0.07), both the ASPR and ASDR continued to rise (EAPC=0.06 and 0.05, respectively). Across SDI quintiles, high-SDI regions ranked highest in all three indicators; middle-high SDI regions had the lowest ASIR and ASPR, while middle-low SDI regions had the lowest ASDR. Regionally, Tropical Latin America recorded the highest ASIR, while Oceania reported the highest ASPR and ASDR; East Asia showed the lowest values across all three indicators. At the national level, New Zealand had the highest ASIR, ASPR, and ASDR; China reported the lowest ASIR, and the Democratic People’s Republic of Korea had the lowest ASPR and ASDR. The burden was positively correlated with SDI, particularly for ASPR and ASDR. By age group, the greatest increase in incidence was observed among women aged 35–39 years, while the 45–49 age group showed the largest rises in prevalence and DALYs. Over the past three decades, health inequalities have shown little improvement. Projections suggest that by 2041, ASIR, ASPR, and ASDR may slightly decline, but the overall burden will remain high Conclusion: From 1990 to 2021, the global burden of bipolar disorder among women of reproductive age rose markedly, with significant disparities. Context-specific strategies, including early screening and long-term management, are essential to reduce burden and improve mental health.
Keywords: Bipolar Disorder, Women of reproductive age, Global burden of disease, Disability-adjusted life years, sociodemographic index
Received: 31 Jul 2025; Accepted: 15 Oct 2025.
Copyright: © 2025 Hu, Zhang, He, Zhang, Zhang, Song and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Chuanfu Song, songchfu@163.com
Cheng Yang, chengyangyc2014@163.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.